It has been reported that Novo Nordisk may have inadvertently allowed generics of its GLP-1 agonist semaglutide, the active ingredient in diabetes therapy Ozempic and obesity drug Wegovy, into the ...

How can the UK accelerate medical innovation at a time when health systems are under strain and investment is slipping away? That question dominated conversations at the recent PharmaTech Integrates ...

Khadija Khartit is a strategy, investment, and funding expert, and an educator of fintech and strategic finance in top universities. She has been an investor, entrepreneur, and advisor for more than ...

Jason Fernando is a professional investor and writer who enjoys tackling and communicating complex business and financial problems. Natalya Yashina is a CPA, DASM with over 12 years of experience in ...

Steam rises from a smoke stack at sunset in Lansing, Michigan, U.S., January 17, 2018. REUTERS/Brendan McDermid/File Photo The Trump administration's imminent repeal of an Obama-era scientific finding ...